206 related articles for article (PubMed ID: 34511037)
1. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.
Chen X; Ma H; Gao Y; Jin Y; Ning W; Hou Y; Su J
Bioengineered; 2021 Dec; 12(1):6738-6747. PubMed ID: 34511037
[TBL] [Abstract][Full Text] [Related]
2. Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway.
Jin SS; Lin CJ; Lin XF; Zheng JZ; Guan HQ
Ann Hepatol; 2022; 27(2):100584. PubMed ID: 34808393
[TBL] [Abstract][Full Text] [Related]
3. Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.
Hu MJ; Long M; Dai RJ
Mol Cell Biochem; 2022 Jan; 477(1):191-203. PubMed ID: 34652536
[TBL] [Abstract][Full Text] [Related]
4. CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease.
Yuan X; Li Y; Wen S; Xu C; Wang C; He Y; Zhou L
Lipids Health Dis; 2022 Nov; 21(1):127. PubMed ID: 36443854
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis.
Cui J; Wang Y; Xue H
Bioengineered; 2022 Apr; 13(4):8370-8381. PubMed ID: 35322757
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA H19 protects against intracerebral hemorrhage injuries via regulating microRNA-106b-5p/acyl-CoA synthetase long chain family member 4 axis.
Chen B; Wang H; Lv C; Mao C; Cui Y
Bioengineered; 2021 Dec; 12(1):4004-4015. PubMed ID: 34288826
[TBL] [Abstract][Full Text] [Related]
7. GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis.
Chen T; Meng Y; Zhou Z; Li H; Wan L; Kang A; Guo W; Ren K; Song X; Chen Y; Zhao W
Cell Death Differ; 2023 Jul; 30(7):1829-1848. PubMed ID: 37337032
[TBL] [Abstract][Full Text] [Related]
8. LncRNA Gm28382 promotes lipogenesis by interacting with miR-326-3p to regulate ChREBP signaling pathway in NAFLD.
Yang S; Zhang Y; Zhang Y; Yin L; Han X; Zhao X; Wang N; Xu L
Int Immunopharmacol; 2024 Jan; 127():111444. PubMed ID: 38157698
[TBL] [Abstract][Full Text] [Related]
9. LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation
Xu S; Wang Y; Li Z; Hua Q; Jiang M; Fan X
Front Endocrinol (Lausanne); 2022; 13():889858. PubMed ID: 35957809
[TBL] [Abstract][Full Text] [Related]
10. LncRNA ZFAS1 ameliorates injury led by non-alcoholic fatty liver disease via suppressing lipid peroxidation and inflammation.
Liu L; Sun S; Li X
Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102067. PubMed ID: 36513253
[TBL] [Abstract][Full Text] [Related]
11. Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206.
Chen X; Tan QQ; Tan XR; Li SJ; Zhang XX
Cell Death Dis; 2021 Aug; 12(9):809. PubMed ID: 34446693
[TBL] [Abstract][Full Text] [Related]
12. Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.
Zheng C; Nie H; Pan M; Fan W; Pi D; Liang Z; Liu D; Wang F; Yang Q; Zhang Y
J Ethnopharmacol; 2024 Jan; 318(Pt A):116967. PubMed ID: 37506783
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis.
Guo B; Cheng Y; Yao L; Zhang J; Lu J; Qi H; Chen H
Cell Signal; 2022 Feb; 90():110190. PubMed ID: 34774989
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes.
Wang XY; Lu LJ; Li YM; Xu CF
Life Sci; 2022 Nov; 308():120925. PubMed ID: 36057399
[TBL] [Abstract][Full Text] [Related]
15. MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1.
Ding J; Xia C; Cen P; Li S; Yu L; Zhu J; Jin J
Mol Biol Rep; 2022 Aug; 49(8):7297-7305. PubMed ID: 35606603
[TBL] [Abstract][Full Text] [Related]
16. MiR-192-5p Ameliorates Hepatic Lipid Metabolism in Non-Alcoholic Fatty Liver Disease by Targeting
Ma L; Song H; Zhang CY; Hou D
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254634
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p/TXNIP axis.
Yang J; Wu L; Liu S; Hu X; Wang Q; Fang L
Med Microbiol Immunol; 2021 Jun; 210(2-3):121-132. PubMed ID: 33885954
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA MALAT1 Regulates the Progression of Atherosclerosis by miR-330-5p/NF-κB Signal Pathway.
Shi Z; Zheng Z; Lin X; Ma H
J Cardiovasc Pharmacol; 2021 Aug; 78(2):235-246. PubMed ID: 34554676
[TBL] [Abstract][Full Text] [Related]
19. Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression.
Cheng L; Yu P; Li F; Jiang X; Jiao X; Shen Y; Lai X
Hum Cell; 2021 Nov; 34(6):1697-1708. PubMed ID: 34410623
[TBL] [Abstract][Full Text] [Related]
20. A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axis.
Li J; Qi J; Tang Y; Liu H; Zhou K; Dai Z; Yuan L; Sun C
J Nanobiotechnology; 2021 Nov; 19(1):363. PubMed ID: 34789275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
